Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
June 11, 2020 - Pfizer announced the FDA approval of Nyvepria (pegfilgrastim-apgf), a biosimilar to Amgen’s Neulasta® (pegfilgrastim).
Download PDF
Return to publications
